Philips 2011: From Light Bulbs to Health Tech

Situation

It is 2011. Frans van Houten becomes CEO of Royal Philips, a Dutch industrial icon founded in 1891 and known worldwide, for over a century, by one thing above all: light bulbs. Over the decades Philips sprawled into a conglomerate — lighting, consumer electronics (TVs, shavers, audio), domestic appliances, and a substantial healthcare business (medical imaging, patient monitoring).

The strategic problem is commoditization of the businesses that built the company:

• Lighting is being upended by LEDs: prices are collapsing, the product is becoming a commodity, and Asian manufacturers compete ferociously. The century-old crown jewel is becoming a low-margin slog.
• Consumer electronics (TVs especially) is a brutal, race-to-the-bottom business that has destroyed margins across the industry.

Meanwhile, the healthcare and personal-health businesses are higher-margin, more defensible, relationship-based, and aligned with powerful structural tailwinds: aging populations and rising global health spending for decades to come.

Van Houten faces a question of corporate identity, not just portfolio tinkering: keep Philips as a diversified conglomerate spanning everything from light bulbs to MRI scanners — or do something radical: progressively dismantle the very businesses that made Philips famous, including its founding lighting division, and reinvent the company as a focused health-technology firm.

The decision moment

It is 2011 onward. Van Houten must choose Philips's future:

1. Reinvent as a focused health-technology company — divest the rest. Systematically exit lighting (spin it off as a separate company, Signify) and shed consumer electronics/TVs and other non-core units, concentrating all capital, R&D, talent, and brand identity on health technology — imaging, monitoring, and health informatics, plus consumer health (e.g. oral care, mother-and-child). Bet that focus on a high-margin, tailwind-backed sector beats the diversified safety of a conglomerate. Wrenching: it means killing the businesses that are Philips in the public mind, over many painful years.
2. Stay a diversified conglomerate; fix each business. Keep the portfolio and try to defend lighting against LEDs, compete in consumer electronics, and grow healthcare — spreading bets and risk. Less identity-shattering, but it keeps capital trapped in commoditizing businesses and denies healthcare the focus and investment to truly lead.
3. Harvest and return cash. Treat the declining businesses as cash cows to be milked while returning capital to shareholders, investing little in transformation. Lower effort, but it manages decline rather than building a future, and likely cedes the health-tech opportunity to focused rivals (GE Healthcare, Siemens Healthineers).

You are Frans van Houten.

Key datapoints (for reference)

Frameworks invoked

• Corporate Portfolio Strategy. A conglomerate's value can be less than the sum of its parts when capital is trapped in declining businesses and management attention is spread thin. Active portfolio management — divesting commoditizing units to concentrate on the highest-value, most defensible one — can unlock value and identity that diversification obscures.
• Focus vs Diversification. Diversification feels safe (multiple bets), but in a company being commoditized from several directions at once, it can mean being mediocre everywhere. Choosing one arena to win — health tech — concentrates the resources needed to actually lead, at the cost of the hedging that breadth provides. (Compare LEGO's "grow by doing less.")
• Escaping Commoditization. Lighting and TVs were sliding toward commodity economics (price wars, Asian scale). The strategic escape is to exit the commoditizing business and redeploy into one where differentiation and relationships still command margin — imaging systems, hospital partnerships, recurring software/informatics revenue.
• Reinvention as a Multi-Year Divestiture. Transforming identity isn't a single decision — it's a decade of disciplined divestitures (lighting → Signify, CE exits) executed without losing the market's confidence. The hard part is sequencing the dismantling of your famous past while building credibility in your unproven future. And focus concentrates risk: a single quality crisis in the chosen arena now threatens the whole company.

Discussion questions

1. Philips exited the lighting business that defined it for 120 years. When is it right to kill the business that is your brand — and how do you tell strategic reinvention from abandoning your roots?
2. Diversification is usually framed as risk reduction. Why did concentrating on a single sector (health tech) become the less risky choice for Philips — and when would it be the more risky one?
3. The transformation took a decade of divestitures. What are the dangers of a slow, multi-year reinvention, and how do you keep markets and employees confident through it?
4. After refocusing, Philips was hit by a massive respiratory-device recall (Respironics). How does focus change the company's risk profile — does concentrating on one arena make a single crisis more dangerous?
5. GE (which dismantled its conglomerate painfully) and Siemens (which spun off Healthineers) faced similar choices. What does the broad retreat from the conglomerate model tell us about modern corporate strategy?

The real outcome (revealed at session end)

2011–2020: Van Houten executes the transformation. Philips spins off its lighting business as Signify (a separately listed company), exits consumer electronics/TVs (licensing the brand), and sheds other non-core units — progressively dismantling the businesses that made it famous. It pours capital and identity into health technology: medical imaging, patient monitoring, and health informatics, alongside consumer health (oral care, mother-and-child). Philips repositions itself, credibly, as a focused health-tech company competing with GE Healthcare and Siemens Healthineers.

2021 — the focus cuts both ways: Philips's Respironics unit issues a massive recall of millions of respiratory devices (CPAP/ventilators) over a foam-degradation safety issue. Because Philips had concentrated its identity and fortunes on health, the crisis strikes at the core of the new company — hammering the share price, inviting regulatory and legal action, and demonstrating that the focused strategy, while escaping commoditization, concentrated quality and reputational risk into the one arena that now mattered most.

The lesson: Sometimes survival means dismantling the business that is your brand. Philips escaped the commoditization of lighting and consumer electronics by doing something most century-old icons can't bring themselves to do — exiting its founding business to concentrate on a higher-value, tailwind-backed arena. Focus unlocked value and a coherent identity that the sprawling conglomerate had buried. But the same focus is a double-edged sword: concentrating on one sector means a single crisis in that sector (the Respironics recall) can imperil the whole company. Reinvention by divestiture can be the right strategy and raise the stakes of getting your new core's execution and quality exactly right.

Sources

• Royal Philips annual reports and strategy disclosures (2011 onward); Signify spin-off filings.
• Coverage of Philips's transformation under Frans van Houten (Financial Times, Reuters).
• Reporting on the Philips Respironics recall (2021) and its consequences.
• Analyses of the decline of the conglomerate model (GE, Siemens, Philips).